# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001370053-22-000064
Filing Date
2022-11-08
Accepted
2022-11-08 16:08:53
Documents
48
Period of Report
2022-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | anab-20221108.htm iXBRL | 8-K | 34349
2 | EX-99.1 | q32022earningsrelease.htm | EX-99.1 | 99570
3 | EX-99.2 | anabcorporateoverviewnov.htm | EX-99.2 | 40641
8 |  | anabcorporateoverviewnov001.jpg | GRAPHIC | 58418
9 |  | anabcorporateoverviewnov002.jpg | GRAPHIC | 228176
10 |  | anabcorporateoverviewnov003.jpg | GRAPHIC | 195056
11 |  | anabcorporateoverviewnov004.jpg | GRAPHIC | 134576
12 |  | anabcorporateoverviewnov005.jpg | GRAPHIC | 57843
13 |  | anabcorporateoverviewnov006.jpg | GRAPHIC | 126550
14 |  | anabcorporateoverviewnov007.jpg | GRAPHIC | 141496
15 |  | anabcorporateoverviewnov008.jpg | GRAPHIC | 151859
16 |  | anabcorporateoverviewnov009.jpg | GRAPHIC | 69109
17 |  | anabcorporateoverviewnov010.jpg | GRAPHIC | 121682
18 |  | anabcorporateoverviewnov011.jpg | GRAPHIC | 142916
19 |  | anabcorporateoverviewnov012.jpg | GRAPHIC | 142241
20 |  | anabcorporateoverviewnov013.jpg | GRAPHIC | 119724
21 |  | anabcorporateoverviewnov014.jpg | GRAPHIC | 175861
22 |  | anabcorporateoverviewnov015.jpg | GRAPHIC | 130197
23 |  | anabcorporateoverviewnov016.jpg | GRAPHIC | 169742
24 |  | anabcorporateoverviewnov017.jpg | GRAPHIC | 134080
25 |  | anabcorporateoverviewnov018.jpg | GRAPHIC | 166101
26 |  | anabcorporateoverviewnov019.jpg | GRAPHIC | 153950
27 |  | anabcorporateoverviewnov020.jpg | GRAPHIC | 152859
28 |  | anabcorporateoverviewnov021.jpg | GRAPHIC | 179341
29 |  | anabcorporateoverviewnov022.jpg | GRAPHIC | 57134
30 |  | anabcorporateoverviewnov023.jpg | GRAPHIC | 142859
31 |  | anabcorporateoverviewnov024.jpg | GRAPHIC | 173772
32 |  | anabcorporateoverviewnov025.jpg | GRAPHIC | 57320
33 |  | anabcorporateoverviewnov026.jpg | GRAPHIC | 159044
34 |  | anabcorporateoverviewnov027.jpg | GRAPHIC | 117453
35 |  | anabcorporateoverviewnov028.jpg | GRAPHIC | 172024
36 |  | anabcorporateoverviewnov029.jpg | GRAPHIC | 175491
37 |  | anabcorporateoverviewnov030.jpg | GRAPHIC | 77934
38 |  | anabcorporateoverviewnov031.jpg | GRAPHIC | 174101
39 |  | anabcorporateoverviewnov032.jpg | GRAPHIC | 191259
40 |  | anabcorporateoverviewnov033.jpg | GRAPHIC | 43474
| Complete submission text file | 0001370053-22-000064.txt |  | 6572585

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | anab-20221108.xsd | EX-101.SCH | 2175
5 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | anab-20221108_def.xml | EX-101.DEF | 8981
6 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | anab-20221108_lab.xml | EX-101.LAB | 33134
7 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | anab-20221108_pre.xml | EX-101.PRE | 20654
42 | EXTRACTED XBRL INSTANCE DOCUMENT | anab-20221108_htm.xml | XML | 10999

Mailing Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121
Business Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121 858-362-6295
ANAPTYSBIO, INC (Filer) CIK: 0001370053 (see all company filings)

EIN.: 203828755 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37985 | Film No.: 221368942
SIC: 2834 Pharmaceutical Preparations